The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Targeted drug delivery via the folate receptor
Sudimack, J., & Lee, R. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00062-9 · Cited by 1,474
Natural selection of tumor variants in the generation of “tumor escape” phenotypes
Khong, H. T., & Restifo, N. P. (2002) · Nature Immunology · doi:10.1038/ni1102-999 · Cited by 1,058
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Frasca, V., Zurawski, V. R., & Kamen, B. A. (1992) · PubMed · Cited by 1,011
COLEY, W. B. (1893) · The American Journal of the Medical Sciences · doi:10.1097/00000441-189305000-00001 · Cited by 995
COLEY, W. B. (1991) · PubMed · Cited by 965
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Self-citationDelivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
Lee, R. J., & Low, P. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41848-5 · Cited by 692
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications
van de Winkel, J. G. J., & Capel, P. J. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90166-i · Cited by 692
Identification of human cancers deficient in antigen processing.
Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mulé, J. J., Rosenberg, S. A., & Bennink, J. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.265 · Cited by 624
Overexpression of folate binding protein in ovarian cancers
Toffoli, G., Cernigoi, C., Russo, A., Gallo, A., Bagnoli, M., & Boiocchi, M. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970422)74:2<193::aid-ijc10>3.0.co;2-f · Cited by 521
Weiner, G. J., Liu, H.-M., Wooldridge, J. E., Dahle, C. E., & Krieg, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10833 · Cited by 519
Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., & Zalipsky, S. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9801124 · Cited by 468
Goren, D., Horowitz, A. T., Tzemach, D., Tarshish, M., Zalipsky, S., & Gabizón, A. (2000) · PubMed · Cited by 468
Immune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
Wiemann, B., & Starnes, C. O. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90023-x · Cited by 467
Folate-binding protein is a marker for ovarian cancer.
Campbell, I., Jones, T. A., Foulkes, W. D., & Trowsdale, J. (1991) · PubMed · Cited by 457
Matherly, L. H., & Goldman, I. D. (2003) · Vitamins & Hormones · doi:10.1016/s0083-6729(03)01012-4 · Cited by 386
Saponins as vaccine adjuvants.
Kensil, C. R. (1996) · PubMed · Cited by 350
Interferon-alpha in tumor immunity and immunotherapy
Belardelli, F., Ferrantini, M., Proietti, E., & Kirkwood, J. M. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00022-3 · Cited by 337
Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
Bukowski, R. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1198::aid-cncr3>3.0.co;2-h · Cited by 325
Human tumor antigens for cancer vaccine development
Wang, R., & Rosenberg, S. A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01331.x · Cited by 296
Taking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258
Interferon-alpha as an immunotherapeutic protein.
Brassard, D., Grace, M. J., & Bordens, R. W. (2002) · PubMed · Cited by 247
Ross, J. F., Wang, H., Behm, F. G., Mathew, P., Wu, M., Booth, R., & Ratnam, M. (1999) · Cancer · Cited by 225
Synthesis and Biological Evaluation of EC20: A New Folate-Derived, 99mTc-Based Radiopharmaceutical
Leamon, C. P., Parker, M. A., Vlahov, I. R., Xu, L.-C., Reddy, J. A., Vetzel, M., & Douglas, N. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0200430 · Cited by 210
Konda, S. D., Aref, M., Wang, S., Brechbiel, M., & Wiener, E. C. (2001) · Magnetic Resonance Materials in Physics, Biology and Medicine · doi:10.1007/bf02668091 · Cited by 210
Wu, M., Gunning, W. T., & Ratnam, M. (1999) · PubMed · Cited by 210
Immune responses to malignancies
Whiteside, T. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.045 · Cited by 204
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity
Marciani, D. J., Press, J. B., Reynolds, R. C., Pathak, A. K., Pathak, V., Gundy, L. E., Farmer, J. T., Koratich, M. S., & May, R. D. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00118-3 · Cited by 196
Endocytosis of GPI-linked membrane folate receptor-alpha.
Rijnboutt, S., Jansen, G., Posthuma, G., Hynes, J. B., Schornagel, J. H., & Strous, G. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.35 · Cited by 192
Targeting gene therapy to cancer: a review.
Dachs, G. U., Dougherty, G. J., Stratford, I. J., et al. (1997) · PubMed · Cited by 187
Low, Y. L. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0266-6 · Cited by 184
Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ Receptors
Anderson, C. F., & Mosser, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3697 · Cited by 178
Shukla, S., Wu, G., Chatterjee, M., Yang, W., Sekido, M., Diop, L. A., Müller, R., Sudimack, J. J., Lee, R. J., Barth, R. F., et al. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025586o · Cited by 174
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
Reddy, J. A., Abburi, C., Hofland, H., Howard, S. J., Vlahov, I., Wils, P., & Leamon, C. P. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301833 · Cited by 173
Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects
Lu, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00215-3 · Cited by 172
Self-citationImmune responses to tumour antigens: implications for antigen specific immunotherapy of cancer
Jager, D., Jager, E., & Knuth, A. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.9.669 · Cited by 168
Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines
Baldridge, J. R., & Crane, R. T. (1999) · Methods · doi:10.1006/meth.1999.0834 · Cited by 168
Toffoli, G., Russo, A. G., Gallo, A., Cernigoi, C., Miotti, S., Sorio, R., & Boiocchi, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2<121::aid-ijc4>3.0.co;2-v · Cited by 164
Monoclonal antibody therapy for solid tumors
Green, M. C., Murray, J. L., & Hortobágyi, G. N. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0176 · Cited by 157
The α folate receptor is highly activated in malignant pleural mesothelioma
Bueno, R., Appasani, K., Mercer, H., et al. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111176 · Cited by 155
CpG Are Efficient Adjuvants for Specific CTL Induction Against Tumor Antigen-Derived Peptide
Miconnet, I., Koenig, S., Speiser, D. E., Krieg, A. Μ., Guillaume, P., Cerottini, J., & Romero, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1212 · Cited by 147
Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
Bödey, B., Bodey, B., Siegel, S. E., & Kaiser, H. E. (2000) · PubMed · Cited by 143
Immunologic mechanisms of antitumor activity
Foss, F. M. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.33076 · Cited by 136
Siegel, B. A., Dehdashti, F., Mutch, D. G., Podoloff, D. A., Wendt, R. E., Sutton, G. P., Burt, R. W., Ellis, P. R., Mathias, C. J., Green, M. A., et al. (2003) · PubMed · Cited by 136
I. The Treatment of Malignant Tumors by Repeated Inoculations of Erysipelas
COLEV, W. B. (1893) · Annals of Surgery · doi:10.1097/00000658-189307000-00009 · Cited by 134
Immunotherapeutic perspective for bispecific antibodies
van Spriel, A. B., van Ojik, H. H., & van de Winkel, J. G. J. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01659-5 · Cited by 133
Korbelik, M., & Cecić, I. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00349-8 · Cited by 132
Immunodeficiency and cancer: prospects for correction
Hadden, J. W. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00060-2 · Cited by 131
Antibody-Targeted Immunotherapy for Treatment of Malignancy
White, C. A., Weaver, R. L., & Grillo-López, A. J. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.125 · Cited by 130
Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy
Xu, L., Pirollo, K. F., & Chang, E. H. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00324-8 · Cited by 128
Folate‐maytansinoids: Target‐selective drugs of low molecular weight
Ladino, C. A., Chari, R. V. J., Bourret, L. A., Kedersha, N., & Goldmacher, V. S. (1997) · International Journal of Cancer · Cited by 120
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy
Dredge, K. S., Marriott, B. J., Todryk, S. M., & Dalgleish, A. G. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0309-z · Cited by 114
Selective Targeting of Malignant Cells with Cytotoxin-Folate Conjugates
Leamon, C. P., & Low, P. S. (1994) · Journal of drug targeting · doi:10.3109/10611869409015898 · Cited by 101
Keyhole limpet hemocyanin conjugate vaccines against cancer: The Memorial Sloan Kettering experience
Musselli, C., Livingston, P. O., & Ragupathi, G. (2001) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01470995 · Cited by 92
Farah, C. S., Elahi, S., Pang, G., Gotjamanos, T., Seymour, G. J., Clancy, R. L., & Ashman, R. B. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6110-6118.2001 · Cited by 90
Franzke, A., Peest, D., Probst‐Kepper, M., Buer, J., Kirchner, G. I., Brabant, G. E., Kirchner, H. H., Ganser, A., & Atzpodien, J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.529 · Cited by 87
Multiple pathways to tumor immunity and concomitant autoimmunity
Turk, M. J., Wolchok, J. D., Guevara-Patino, J. A., Goldberg, S. M., & Houghton, A. N. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18811.x · Cited by 83
Optical imaging of metastatic tumors using a folate-targeted fluorescent probe
Kennedy, M. D., Jallad, K. N., Thompson, D. H., Ben‐Amotz, D., & Low, P. S. (2003) · Journal of Biomedical Optics · doi:10.1117/1.1609453 · Cited by 82
Ernst, L. K., Metes, D., Herberman, R. B., & Morel, P. A. (2001) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0294-2 · Cited by 81
Tumor escape from immune surveillance.
Costello, R. T., Gastaut, J. A., & Olive, D. (1999) · PubMed · Cited by 74
Peoples, G. E., Anderson, B. W., Lee, T. V., Murray, J. L., Kudelka, A. P., Wharton, J. T., & Ioannides, C. G. (1999) · PubMed · Cited by 59
Immunotherapy of cancer using heat shock proteins
Masoud, H. M. (2002) · Frontiers in bioscience · doi:10.2741/manjili · Cited by 57
Visualizing the course of antigen‐specific CD8 and CD4 T cell responses to a growing tumor
Klein, L., Trautmann, L., Psarras, S., Schnell, S., Siermann, A., Liblau, R., von Boehmer, H., & Khazaie, K. (2003) · European Journal of Immunology · doi:10.1002/eji.200323800 · Cited by 57
Evaluation of Folate Conjugate Uptake and Transport by the Choroid Plexus of Mice
Kennedy, M. D., Jallad, K. N., Lu, J., Low, P. S., & Ben‐Amotz, D. (2003) · Pharmaceutical Research · doi:10.1023/a:1023421232689 · Cited by 54
Adjuvant immunotherapy for solid tumors: from promise to clinical application
D, S. M. M., Rossi, C. R., Lise, M., & Marincola, F. M. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0308-0 · Cited by 54
Starnes, C. O. (1992) · Nature · doi:10.1038/360023b0 · Cited by 53
T-Cell Adoptive Therapy of Tumors: Mechanisms of Improved Therapeutic Performance
Peng, L., Cohen, P. A., Kjærgaard, J., Plautz, G. E., Finke, J. H., Koski, G. K., Czerniecki, B. J., & Shu, S. (2001) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v21.i1-3.150 · Cited by 51
Single-Chain Fv/Folate Conjugates Mediate Efficient Lysis of Folate-Receptor-Positive Tumor Cells
Cho, B. K., Roy, E. J., Patrick, T. A., & Kranz, D. M. (1997) · Bioconjugate Chemistry · doi:10.1021/bc9700244 · Cited by 44
Rodolfo, M., Melani, C. C., Zilocchi, C., Cappetti, B., Luison, E., Arioli, I., Parenza, M., Canevari, S., & Colombo, M. P. (1998) · PubMed · Cited by 42
Steplewski, Z., Lubeck, M. D., Scholz, D., et al. (1992) · PubMed · Cited by 33
Cohen, Y., Polliack, A., Zelig, O., & Goldfarb, A. W. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097770 · Cited by 33
The Functional Relevance of NK-Cell-Mediated Upregulation of Antigen-Specific IgG2a Responses
Koh, C. Y., & Yuan, D. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1703 · Cited by 28
Bispecific agents target endogenous murine T cells against human tumor xenografts
Rund, L. A., Cho, B. K., Manning, T. C., Holler, P. D., Roy, E. J., & Kranz, D. M. (1999) · International Journal of Cancer · Cited by 26
Tirapu, I., Mazzolini, G. D., Rodrı́guez-Calvillo, M., Arina, A., Palencia, B., Gabari, I., & Melero, I. (2002) · PubMed · Cited by 22
Characterization of a High-Affinity Folate Receptor in Normal and Malignant Human Testicular Tissue
Holm, J., Hansen, S. I., Høier‐Madsen, M., Christensen, T. B., & Nichols, C. W. (1999) · Bioscience Reports · doi:10.1023/a:1020219029206 · Cited by 16
Targeted immunotherapy of cancer: development of antibody-induced cellular immunity
Lu, Y. J., & Low, P. S. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702540 · Cited by 11
Self-citationFolate Gains Momentum as a Vehicle for Drug Delivery
Vastag, B. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1800 · Cited by 6
Lussow, A. R., Fanget, L., Gao, L., Block, M., Buelow, R., & Pouletty, P. (1996) · Transplantation · doi:10.1097/00007890-199612270-00001 · Cited by 4
Cited by
Kam, N. W. S., O'Connell, M., Wisdom, J. A., & Dai, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502680102 · Cited by 2,307
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Insight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
Gupta, A. K., Naregalkar, R. R., Vaidya, V. D., & Gupta, M. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.23 · Cited by 708
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
Hilgenbrink, A. R., & Low, P. S. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20457 · Cited by 625
Metadata
- Authors
- Lu, Y.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-04-29
- Volume
- 56
- Issue
- 8
- Pages
- 1161-1176
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2089319551
- Cited by
- 256
- References
- 80
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.